Carbetapentane and guaifenesin and Tranzarel Gel

• Generic Name: carbetapentane / guaifenesin
• Dosage Forms: n.a.
• Other Brand Names: Allfen C, Allfen CX, Xpect-AT, BetaVent, Oratuss, Pulmari-GP, Certuss, Dynex VR, Carba-XP, AMBI 1000/5, Duratuss CS, Respi-Tann G, Allres-G, Tusso-ZR, Tusso-ZMR, exall, Expectuss

Carbetapentane is a cough suppressant. It affects the signals in the brain that trigger cough reflex.

Guaifenesin is an expectorant. It helps loosen mucus congestion in your chest and throat, making it easier to cough out through your mouth.

Carbetapentane and guaifenesin is a combination medicine used to treat stuffy nose, cough, and chest congestion caused by the common cold or flu.

carbetapentane and guaifenesin will not treat a cough that is caused by smoking, asthma, or emphysema.

Carbetapentane and guaifenesin may also be used for purposes not listed in this medication guide.

• Generic Name: lidocaine topical
• Dosage Forms: gel
• Other Brand Names: Aloe Vera Burn Relief Spray with Lidocaine, AneCream, Bactine, Glydo, LidaMantle, Lidoderm, LidoRx, Medi-Quik Spray, RadiaGuard, Regenecare HA Spray, Solarcaine Aloe Extra Burn Relief, Lidocaine viscous, LidoRxKit, LTA II Kit, AneCream with Tegaderm, Anestacon, Lidocream, Lidosense5, LMX 4, LMX 4 with Tegaderm, LMX 5, Senatec, Xylocaine Jelly, Xylocaine Topical, Zilactin-L, L-M-X4, Preparation H, RectiCare, Solarcaine Aloe Extra, ZTlido

Treatment of major depressive disorder without melancholia.

Efficacy in major depressive disorder with melancholia (endogenous features) not established.

MAO inhibitors appear particularly effective in treatment of major depressive disorder with atypical features, although other antidepressants (e.g., SSRIs) may initially be used because of their more favorable adverse effect profile.

Because of potential for serious adverse effects and necessity of dietary restrictions, MAO inhibitors (e.g., phenelzine, tranylcypromine) generally are not used as initial therapy for major depressive disorder, but are reserved for carefully selected patients who can be closely supervised and who have depression refractory to other antidepressants (e.g., SSRIs, SNRIs, TCAs) or in whom other therapies are contraindicated.